Charles Schwab
ARMP icon

Charles Schwab’s Armata Pharmaceuticals ARMP Stock Holding History

Charles Schwab’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Buy
+28,857
New +$265K ﹤0.01% 3377

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Charles Schwab's ARMP Position: Q2 2026 in Review

Charles Schwab opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 28,857 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #3377 among its holdings.

53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Charles Schwab held 28,857 shares of Armata Pharmaceuticals worth $187K as of Q2 2026.
  • Armata Pharmaceuticals was a new Charles Schwab position in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3377 holding.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.